BIOMAT Database Logo BIOMAT Database Logo

[Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis]. 1995

S Haas
Institut für Experimentelle Chirurgie, der Technischen Universität, München.

UI MeSH Term Description Entries
D004087 Dihydroergotamine A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. Agit,Angionorm,Clavigrenin,D-Tamin Retard L.U.T.,D.H.E. 45,DET MS,DHE-45,DHE-Puren,DHE-Ratiopharm,Dihydergot,Dihydroergotamin AL,Dihydroergotamine Mesylate,Dihydroergotamine Methanesulfonate,Dihydroergotamine-Sandoz,Dihytamin,Erganton,Ergomimet,Ergont,Ergotam Von Ct,Ikaran,Migranal,Orstanorm,Seglor,Tamik,Verladyn,D Tamin Retard L.U.T.,DHE 45,DHE Puren,DHE Ratiopharm,DHE45,Dihydroergotamine Sandoz,Mesylate, Dihydroergotamine,Methanesulfonate, Dihydroergotamine,Von Ct, Ergotam
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

S Haas
The influence of low molecular weight heparin in combination with dihydroergotamine on experimental thrombosis and haemostasis.
October 1987, Thrombosis and haemostasis,
S Haas
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
July 1988, The British journal of surgery,
S Haas
Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
September 1986, The British journal of surgery,
S Haas
[Thrombosis prevention with low molecular weight heparin].
July 1987, Medizinische Monatsschrift fur Pharmazeuten,
S Haas
Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
January 1989, VASA. Zeitschrift fur Gefasskrankheiten,
S Haas
Low-molecular-weight heparin for prevention of thrombosis: inverted role.
November 2007, The Journal of trauma,
S Haas
Low molecular weight heparin in prevention of perioperative thrombosis.
October 1992, BMJ (Clinical research ed.),
S Haas
[Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
S Haas
[Prevention of thrombosis with unfractionated and low molecular weight heparin].
December 1989, Wiener medizinische Wochenschrift (1946),
S Haas
[Venous thrombosis. After heparin administration, low-molecular-weight heparin for prevention of recurrence].
April 2001, MMW Fortschritte der Medizin,
Copied contents to your clipboard!